For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
Blog
This week in health care policy: September 21–25, 2026
Innovation watch FDA approves the first treatment for Sanfilippo syndrome. On September 17, the FDA approved Ultragenyx’s Fayuvi, a one-time…
Blog
How The No Surprises Act worsened the problem of surprise bills
Next week, Sen. Bill Cassidy (R-LA) will convene a roundtable to discuss adjustments to the 2020 No Surprises Act, which has come under…
Search Posts
Op-Eds
Drug Testing, Drug Hazards
A clinical trial that went badly awry at London's Northwick Park Hospital in March became the drug-testing community's worst nightmare. Six healthy volunteers ended up…
Blog
A typology for risk assessment?
New research may help to explain why the term “risk” shouldn’t automatically be applied to new technologies, such as biotechnology. According to…
Op-Eds
Lance Armstrong’s Self-Inflicted Cancer?
Did the use of performance-enhancing drugs cause seven-time Tour de France winner Lance Armstrong’s testicular cancer? That’s what a Sports Illustrated columnist suggested this…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. HEALTH The Food and Drug Administration approves the first fully implantable artificial heart.
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. ENERGY President Bush makes access to affordable energy the focus of his Labor Day…
Op-Eds
Why spurning food biotech has become a liability
Henry I. Miller, MD, Gregory Conko & Drew L. Kershen By rejecting gene-spliced ingredients in their products, some major food companies may be…